Robotic Surgical Instrument Reprocessing Market Report 2026

The robotic surgical instrument reprocessing market size has grown rapidly in recent years. It will grow from $1.27 billion in 2025 to $1.4 billion in 2026 at a compound annual growth rate (CAGR) of 11%. The growth in the historic period can be attributed to expansion of robotic-assisted surgeries, increasing hospital infection control requirements, growth of central sterile processing departments, rising use of reusable robotic instruments, availability of specialized reprocessing equipment.

The robotic surgical instrument reprocessing market size is expected to see rapid growth in the next few years. It will grow to $2.11 billion in 2030 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to increasing volume of minimally invasive surgeries, rising investments in robotic surgery infrastructure, expansion of outpatient surgical centers, growing demand for cost-efficient instrument reuse, increasing regulatory scrutiny on sterilization processes. Major trends in the forecast period include increasing demand for advanced instrument cleaning systems, rising adoption of automated sterilization technologies, growing focus on reprocessing workflow standardization, expansion of single-use instrument integration, enhanced emphasis on infection control compliance.

The rising adoption of robotic surgeries is expected to propel the growth of the robotic surgical instrument reprocessing market going forward. Robotic surgeries are minimally invasive procedures performed with robotic systems that enhance the surgeon’s precision, control, and flexibility. The uptake of robotic surgeries is increasing due to their ability to improve surgical accuracy and reduce patient recovery time. Robotic surgical instrument reprocessing ensures that these complex instruments are thoroughly cleaned, sterilized, and safely reused for subsequent procedures. For instance, in October 2025, Digital Health Intelligence Limited, a UK-based private health information publisher, reported that by 2035, operations using robotic-assisted surgery (RAS) are projected to reach 500,000 annually, up significantly from approximately 70,000 procedures in 2023-24. Therefore, the growing adoption of robotic surgeries is driving the market for robotic surgical instrument reprocessing.

Companies in the robotic surgical instrument reprocessing market are focusing on innovations such as magnetic resonance imaging (MRI)-compatible robotic surgery platforms to enhance precision, safety, and real-time imaging guidance during minimally invasive procedures. An MRI-compatible robotic surgery platform is designed to operate safely within the magnetic environment of an MRI scanner, offering precise instrument control, real-time imaging, and improved clinical outcomes. For instance, in September 2025, Insight Medbotics, a Canada-based interventional oncology company, launched Glenn, an MRI-compatible robotic surgery platform for prostate cancer procedures. Glenn provides real-time imaging, accurate instrument control, and intuitive access for biopsies and focal therapies, reducing the need for ultrasound guidance and rectal probes, improving patient comfort, and supporting minimally invasive interventions as a next-generation precision solution.

In March 2023, Getinge, a Sweden-based medical technology company, acquired Ultra Clean Systems Inc. for USD $16 million (approximately SEK 170 million). This acquisition strengthens Getinge’s robotic surgical instrument reprocessing capabilities in North America and expands its portfolio of equipment, consumables, and IT solutions. Ultra Clean Systems Inc., based in the U.S., specializes in ultrasonic cleaning systems for surgical instruments, including those used in robotic surgical procedures.

Major companies operating in the robotic surgical instrument reprocessing market are Ecolab Inc., B. Braun Melsungen SE, Zimmer Biomet Holdings Inc., STERIS plc, Getinge AB, Miele & Cie. KG, Acrotec Medtech, Belimed AG, SteraTek, Primo Medical Group, Matachana, Innovative Health, Restore Robotics, MMM Group, Vanguard AG, Medisafe International, Pure Processing, Steelco, ASP (Advanced Sterilization Products), Tuttnauer Ltd.

North America was the largest region in the robotic surgical instrument reprocessing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the robotic surgical instrument reprocessing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the robotic surgical instrument reprocessing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the robotic surgical instrument reprocessing market by increasing costs of imported sterilization equipment, cleaning systems, inspection devices, and specialized consumables. Hospitals and surgical centers in North America and Europe are most affected due to dependence on imported reprocessing technologies, while Asia-Pacific faces higher costs for equipment sourcing. These tariffs are increasing operational expenses and capital investment requirements. However, they are also encouraging domestic manufacturing of reprocessing systems, localized supply of consumables, and innovation in cost-efficient sterilization solutions.

The robotic surgical instrument reprocessing market research report is one of a series of new reports that provides robotic surgical instrument reprocessing market statistics, including robotic surgical instrument reprocessing industry global market size, regional shares, competitors with a robotic surgical instrument reprocessing market share, detailed robotic surgical instrument reprocessing market segments, market trends and opportunities, and any further data you may need to thrive in the robotic surgical instrument reprocessing industry. This robotic surgical instrument reprocessing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Robotic surgical instrument reprocessing is the structured process of cleaning, disinfecting, and sterilizing instruments used in robot-assisted surgeries to ensure they are safe for reuse. This process involves specialized procedures and equipment to effectively remove biological debris from delicate and complex robotic instruments.

The main product types of robotic surgical instrument reprocessing are reusable instruments, single-use instruments, reprocessing equipment, and consumables. Reusable instruments are surgical tools that undergo cleaning, disinfection, and sterilization to be safely used multiple times in robotic surgeries. The reprocessing workflow includes cleaning, disinfection, sterilization, inspection, packaging, and related steps. Primary end-users include hospitals, ambulatory surgical centers, specialty clinics, and other healthcare facilities.

The robotic surgical instrument reprocessing market includes revenues earned by providing services such as preventive maintenance of robotic instruments, calibration and performance validation, staff training for handling and safety protocols, remote monitoring and tracking of instrument usage and regulatory compliance auditing and reporting. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.